Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.
about
High dose chemotherapy with stem cell support in the treatment of testicular cancerCanadian consensus guidelines for the management of testicular germ cell cancer.High-dose chemotherapy and stem cell transplantation for advanced testicular cancerHigh-dose chemotherapy for male germ cell tumor.A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.Transplantation for refractory germ cell tumors: does it really make a difference?The role of high-dose chemotherapy in the treatment of testicular cancer.High-dose chemotherapy for germ cell tumors: do we have a model?Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience.A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumours.Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study.Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse.A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study
P2860
Q26771162-6F13E343-48DD-4CCF-9EA5-0F40DA477C33Q33753786-BA82F8CB-B337-4120-9A18-6A3017286161Q35660641-A86D3EA6-34E4-4068-82D5-2D745ECEE591Q36563573-6D152F35-9867-4A4E-8355-9BA09CC018A4Q37875412-C56E63E2-C386-4F98-8E4B-3F00FA8F4871Q37905875-51F87635-9B56-4F75-BAC8-DEDE11FA5CF4Q38089677-74CA6EC8-FC55-4D62-85DF-4B0C9F68B451Q38160470-7595D130-9FBC-4D34-AF22-6D898B8FCAF6Q38253101-243FEE87-B74C-4152-9872-5E072D38135EQ38666300-96F8A23C-7F62-4D44-AFF9-BBC3C7E1DB0AQ38966419-94E0E686-D6C5-4FA2-AFF6-81B207EFD156Q46255293-478743D9-2D04-49E7-B523-9D7E486B00F6Q46520866-0F23C210-B6AF-4F4D-A125-9441F06B54ACQ50984881-04EC19BE-FBD3-4CF2-A5C2-8F9F3C8FD67BQ53164870-86063029-220F-426F-839B-CB0B4F540C74Q53659584-11F63FC3-B236-4B8A-9975-4B8CE86FED8BQ57579466-A2A5A051-E073-40F8-BEA6-EE928CF42747
P2860
Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Long-term survival after high- ...... adverse prognostic variables.
@en
Long-term survival after high- ...... adverse prognostic variables.
@nl
type
label
Long-term survival after high- ...... adverse prognostic variables.
@en
Long-term survival after high- ...... adverse prognostic variables.
@nl
prefLabel
Long-term survival after high- ...... adverse prognostic variables.
@en
Long-term survival after high- ...... adverse prognostic variables.
@nl
P2093
P356
P1476
Long-term survival after high- ...... adverse prognostic variables.
@en
P2093
Daniel A Vaena
Lawrence H Einhorn
Rafat Abonour
P304
P356
10.1200/JCO.2003.06.067
P407
P577
2003-11-01T00:00:00Z